First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial

Detalles Bibliográficos
Autor principal: Kumaraswamy, Santosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Uroscan
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388336/
https://www.ncbi.nlm.nih.gov/pubmed/34465967
http://dx.doi.org/10.4103/iju.IJU_534_20
_version_ 1783742618796032000
author Kumaraswamy, Santosh
author_facet Kumaraswamy, Santosh
author_sort Kumaraswamy, Santosh
collection PubMed
description
format Online
Article
Text
id pubmed-8388336
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-83883362021-08-30 First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial Kumaraswamy, Santosh Indian J Urol Uroscan Wolters Kluwer - Medknow 2021 2021-07-01 /pmc/articles/PMC8388336/ /pubmed/34465967 http://dx.doi.org/10.4103/iju.IJU_534_20 Text en Copyright: © 2021 Indian Journal of Urology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Uroscan
Kumaraswamy, Santosh
First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial
title First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial
title_full First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial
title_fullStr First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial
title_full_unstemmed First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial
title_short First-line maintenance immunotherapy in advanced urothelial cancers: Practice changing implications of the JAVELIN bladder 100 trial
title_sort first-line maintenance immunotherapy in advanced urothelial cancers: practice changing implications of the javelin bladder 100 trial
topic Uroscan
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388336/
https://www.ncbi.nlm.nih.gov/pubmed/34465967
http://dx.doi.org/10.4103/iju.IJU_534_20
work_keys_str_mv AT kumaraswamysantosh firstlinemaintenanceimmunotherapyinadvancedurothelialcancerspracticechangingimplicationsofthejavelinbladder100trial

Ejemplares similares